Weissella paramesenteroides UFTM 2.6.1: probiotic potential and biotechnological applications
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Lactic Acid Bacteria (LAB) constitute a diverse group of Gram-positive bacteria known for
their production of lactic acid during carbohydrate fermentation. Among them, Weissella
species have emerged as notable candidates for applications in the food and pharmaceutical
industries due to their probiotic, biotechnological, and bacteriocinogenic potential. This study
presents a comprehensive probiogenomic analysis of Weissella paramesenteroides UFTM 2.6.1
isolated from unpasteurized cow's milk from the Triângulo Mineiro region, exploring its
probiotic potential through in vitro and in silico analyses and investigating biotechnological
prospects. Taxonomic characterization confirmed the identity of W. paramesenteroides,
revealing a genome with 1,926 protein-coding genes primarily linked to cell metabolism,
information storage and processing, and cellular processes and signaling. The genome also
harbors over 100 genes associated with probiotic traits, such as stress response, gastrointestinal
persistence, and biosynthesis of vitamins. In silico analysis identified bacteriocin-related genes,
including pediocin, and confirmed in vitro antimicrobial activity of W. paramesenteroides
UFTM 2.6.1 against Listeria spp. Genomic analysis identified pLCK4 replicon and four
prophage regions (one intact), without CRISPR-Cas systems, Cas proteins, resistance, or
virulence genes, suggesting the strain's safety profile. Pan-genome analysis revealed 204 unique
genes in W. paramesenteroides UFTM 2.6.1, encompassing metabolism and stress-related
functions. These findings highlight its probiotic potential. To investigate relevant literature data
on the use of LAB in vaccine strategies, we developed and published an integrative review on
recombinant LAB for vaccine development, highlighting their efficacy as potent vectors for
mucosal and systemic immunization in animal models. Given this biotechnological potential of
LAB, we conducted plasmid design and selection for bacterial integration, resulting in the
efficient cloning of the Receptor Binding Domain (RBD) gene of SARS-CoV-2 in Escherichia
coli, demonstrating significant synthesis in both supernatant and cell lysate, and recognition by
human antibodies. Additionally, we designed a plasmid optimized for LAB, incorporating
cassettes for expressing the SARS-CoV-2 RBD gene and IS1223 insertion sequence. This
design also features celA as a non-toxic screening marker, avoiding antibiotic resistance
concerns. These were preliminary assays that provide insights for future research into LAB,
particularly W. paramesenteroides UFTM 2.6.1, requiring further validation to assess its
potential as a viable vaccine platform and confirm its probiotic characteristics.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

